Daily non-political popular news in brief.

Chronic fatigue -- Clues in the blood

07-06-2007 · EurekAlert!

Researchers at the University of New South Wales (UNSW) believe that blood may hold vital insights into what is happening in the brain of patients with chronic fatigue syndrome (CFS).

Keywords: chronic, fatigue, clues, blood, clue

« Previous | Next »

Similar news on "Chronic fatigue -- Clues in the blood":

Blood protein offers clues to heart attack in seemingly healthy people
07-02-2007 · EurekAlert!
We've all wondered how a seemingly healthy person can actually be at high risk for heart disease or a heart attack. Now researchers have uncovered a new clue to this mystery. The culprit: myeloperoxidase, a protein secreted by white blood cells that both signals inflammation and releases a bleach-like substance that damages the cardiovascular system.
Similar news · Read more »
Sick and Tired: Tracking paths to chronic fatigue
11-11-2006 · Science News Online
Stressful experiences and a genetic predisposition toward emotional turmoil contribute to some cases of chronic fatigue syndrome.
Similar news · Read more »
Novel laboratory model reveals clues to how blood starts clotting
10-26-2006 · EurekAlert!
Researchers at the University of Chicago have crafted a simple model for predicting when and where hemostasis -- the technical term for blood clotting -- will occur. The microfluidic system that they created focuses on the interactions between blood and surfaces patterned to trigger blood clotting. It allows the researchers to separately monitor clotting in both blood plasma and a chemical model.
Similar news · Read more »
MERLIN TIMI-36 study provides new safety and efficacy data for unique anti-anginal therapy
03-27-2007 · EurekAlert!
Chest pain due to a shortage of blood in the heart, known as angina, is a condition that affects millions of Americans. The most recently approved new pharmaceutical approach to treat chronic angina is a novel drug called ranolazine, which was approved in 2006 for use as second line therapy in patients who continue to experience angina despite treatment with another class of anti-anginal medication.
Similar news · Read more »
Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
10-08-2007 · EurekAlert!
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water. This toxic element is currently a significant public health problem in at least 70 countries. Chronic arsenic exposure is associated with increased risk for skin, liver and bladder cancers, skin lesions, cardiovascular disease, and other adverse health outcomes.
Similar news · Read more »
Stress: Brain yields clues about why some succumb while others prevail
10-18-2007 · EurekAlert!
The reason some people don't get post-traumatic stress disorder or depression from chronic stress, while others do, may lie in specific molecular differences in the brain. This study mapped them out in mice responding to stressful situations, in mechanisms also found in human brain. It turns out that the ability to withstand stress isn't just the absence of brain mechanisms that underlie the tendency to buckle under; a different, adaptive molecular engine gets fired up to drive resilience.
Similar news · Read more »
Insights into anemia control in dialysis patients
07-11-2007 · EurekAlert!
Anemia is one of the most frequent complications of hemodialysis, and its correction is an important factor in restoring a tolerable quality of life to dialysis-dependent patients. Treatment with drugs called erythropoiesis-stimulating agents (ESAs), which stimulate the bone marrow to produce red blood cells, have been a major advance in the treatment of the anemia (low levels of red blood cells or hemoglobin, which carries oxygen in the blood) in chronic kidney disease (CKD).
Similar news · Read more »
Nicotine: The link between cigarette smoking and kidney disease progression?
01-29-2007 · EurekAlert!
The mechanisms by which cigarette smoke may accelerate some types of chronic kidney disease are currently unknown. A new study demonstrates for the first time that human mesangial cells (MC) - cells in the blood vessels of the kidneys -- are endowed with nicotinic receptors (nAChRs) á4, á5, á7, â2, â3, â4 and â5 (cells that interact with the nicotine in tobacco) and may play an active role in the development of certain kidney diseases.
Similar news · Read more »
Brain blood flow gives clues to treating depression
08-08-2007 · EurekAlert!
The usefulness of established molecular imaging/nuclear medicine approaches in identifying the "hows" and "whys" of brain dysfunction and its potential in providing immediately useful information in treating depression are emphasized in a study in the August Journal of Nuclear Medicine.
Similar news · Read more »
Pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease
12-12-2007 · EurekAlert!
A new study confirms that chronic kidney disease increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the antidiabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.
Similar news · Read more »